मूलभूत आँकड़े
| CIK | 894560 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bioethics, Ltd.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2024 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) Nevada (NV) 87-0485312 (State or other jurisdiction of incorporation or organization) |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b‑25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20‑F ☐ Form 11‑K ☒ Form 10‑Q ☐ Form 10-D ☐ Form N‑SAR ☐ Form N‑CSR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10‑K ☐ Transition Report on Form 20‑F ☐ Transition Report on Form 11‑K ☐ Transition Report on Form 10‑Q ☐ Transition Report |
|
| September 25, 2024 |
EXHIBIT 99.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among BIOETHICS, LTD., BIOE MERGER SUB, INC. SILQ TECHNOLOGIES CORPORATION THE PRINCIPAL STOCKHOLDERS OF BIOETHICS, LTD. AND THE PRINCIPAL STOCKHOLDERS OF SILQ TECHNOLOGIES CORPORATION dated as of September 18, 2024 1 ARTICLE I THE MERGER 5 1.1 The Merger 5 1.2 Closing 6 1.3 Effective Time 6 1.4 Effect of the Merger 6 1.5 Directors |
|
| September 25, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 20, 2024 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-0485312 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact n |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: June 30, 2024 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] |
|
| June 26, 2024 |
BIOETHICS, LTD 1661 Lakeview Circle Ogden, UT 84403 Telephone: 801-399-3632 BIOETHICS, LTD 1661 Lakeview Circle Ogden, UT 84403 Telephone: 801-399-3632 June 17, 2024 SILQ Technologies Corporation Attn: Verne Sharma, CEO Re:Proposed Transaction Dear Verne: BIOETHICS, LTD, a Nevada corporation (“BIOETHICS”), and SILQ Technologies, a Delaware corporation (“SILQ”), are contemplating a proposed transaction as described below (the “Transaction”). |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 18, 2024 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) (IRS Employer of |
|
| May 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2024 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 26, 2024 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) (IRS Employer of |
|
| April 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2023 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NEVADA (NV) 87-0485312 (State or other jurisdiction of incorporation or organization) |
|
| April 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2023 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2023 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10- |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| November 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 30, 2023 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) (IRS Employer |
|
| November 6, 2023 |
Exhibit 16.1 November 6, 2023 Securities and Exchange Commission (the “Commission”) 100 F Street, NE Washington, DC 20549 Dear Ladies and Gentleman: We are the former independent registered public accounting firm for Bioethics, Ltd. (the “Company”). We have read the statements made by the Company, which were provided to us and which we understand will be filed with the Commission pursuant to Item |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact n |
|
| May 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q/A (Amendment No. 1) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIO |
|
| May 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2023 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| May 15, 2023 |
SEC FILE NUMBER: 000 30239 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2022 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NEVADA (NV) 87-0485312 (State or other jurisdiction of incorporation or organization) |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2022 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| November 14, 2022 |
NT 10-Q 1 bioethics93012b25.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2022 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact n |
|
| August 15, 2022 |
NT 10-Q 1 bioe2022063012b25.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: June 30, 2021 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tr |
|
| May 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-CEN [ ] Form N-CSR For Period Ended: March 31, 2022 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q Fo |
|
| April 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2021 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NEVADA (NV) 87-0485312 (State or other jurisdiction of incorporation or organization) |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2021 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 19, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2021 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10- |
|
| August 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact n |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: June 30, 2021 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] |
|
| May 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q/A (Amendment No. 1) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIO |
|
| May 24, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2021 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| May 17, 2021 |
NT 10-Q 1 12b-25vedgar1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2021 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Trans |
|
| April 15, 2021 |
Annual Report - BIOETHICS, LTD - FORM 10-K SEC FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2020 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NV 87-0485312 (State or other jurisdiction of incorporation or organization) (I.R.S. E |
|
| March 31, 2021 |
NT 10-K 1 bioethics12b25.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2020 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Tra |
|
| December 4, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 30, 2020 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) |
|
| December 4, 2020 |
AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (the “Agreement”) entered into as of November 30, 2020, by and among Bioethics, Ltd. |
|
| November 30, 2020 |
8-K 1 8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 6, 2020 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) (I |
|
| November 30, 2020 |
CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOETHICS, LTD. A Nevada Corporation CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF BIOETHICS, LTD. A Nevada Corporation BIOETHICS, LTD., a corporation organized and existing under the laws of the State of Nevada (the “Corporation”) hereby certifies that the amendment set forth below to the Corporation’s Articles of Incorporation (the “Articles”) was duly adopted in accordance with Sections 78.385 and 78.390 of the Neva |
|
| November 19, 2020 |
10-Q 1 10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 |
|
| November 16, 2020 |
SEC FILE NUMBER: 000 30239 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| July 31, 2020 |
Financial Statements and Exhibits, Other Events 8-K 1 8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 29, 2020 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 33-55254-41 87-0485312 (State or other jurisdiction (Commission File No.) (IRS |
|
| July 31, 2020 | ||
| July 28, 2020 |
10-Q 1 10Q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOET |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2020 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Ex |
|
| April 9, 2020 |
BOTH / Bioethics, Ltd. 10-K - Annual Report - 10-K 1 10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2019 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NEVADA 87-0485312 (State or other jurisdiction of incorporation or organ |
|
| March 31, 2020 |
BOTH / Bioethics, Ltd. NT 10-K - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2019 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| March 5, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 21, 2020 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) (IRS Employer |
|
| March 5, 2020 |
MUTUAL RESCISSION AND RELEASE AGREEMENT MUTUAL RESCISSION AND RELEASE AGREEMENT This MUTUAL RESCISSION AND RELEASE AGREEMENT (“Agreement”) is entered into as of February 24, 2020 (the “Effective Date”), by and between BIOETHICS, LTD. |
|
| March 5, 2020 |
EX-10 3 ex1011.htm ASSIGNMENT AND ASSUMPTION OF CONTRACTS This ASSIGNMENT AND ASSUMPTION OF CONTRACTS ("Assignment Agreement") is executed and delivered as of the date set forth below, by BIOETHICS, LTD., a Nevada corporation ("Assignor"), to FIRST FEDERAL MANAGEMENT GROUP, INC., a Utah corporation (“Assignee”). W I T N E S S E T H: WHEREAS, Assignor and Assignee, entered into that certain Mutual |
|
| January 27, 2020 |
EX-99 8 ex99.1vedgar1vamd1.htm FOR IMMEDIATE RELEASE: January 23, 2020 Mark Scharmann Bioethics, LTD. BOTH 801-543-9302 [email protected] Bioethics LTD. Announces New Course for the Public Company Bioethics and First Federal Management Enter into an Agreement Salt Lake City, Utah: On December 5, 2019, Bioethics LTD. and First Federal Management Corporation entered into a contribution and sub |
|
| January 27, 2020 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION AMENDED AND RESTATED ARTICLES OF INCORPORATION Bioethics, Ltd., a corporation organized and existing under the laws of the State of Nevada, hereby certifies as follows: 1.The name of the corporation is Bioethics, Ltd. The corporation was originally incorporated under the name of Bioethics, Ltd., and the original Articles of Incorporation of the corporation were filed with the Secretary of State of |
|
| January 27, 2020 |
ASSIGNMENT OF LEASES AND RENTS WHEN RECORDED, PLEASE RETURN TO: Parr Brown Gee & Loveless 101 South 200 East, Suite 700 Salt Lake City, Utah 84111 Attention: Robert A. |
|
| January 27, 2020 |
EX-10 6 ex10.8vedgar1vamd1.htm PROMISSORY NOTE $640,000.00Salt Lake City, Utah December, 2019 1.PROMISE TO PAY. FOR VALUE RECEIVED, GREEN HAVEN HOMES, LLC, a Utah limited liability company (“Maker”), with a business address of 13504 South, 7530 West, Herriman, Utah 84096, Attn: Joseph L. Darger, promises to pay to the order of BIOETHICS, LTD., a Nevada corporation, its successors or assigns (“Hold |
|
| January 27, 2020 |
AMENDED & RESTATED PROMISSORY NOTE EX-10 4 ex10.6vedgar1vamd2.htm AMENDED & RESTATED PROMISSORY NOTE $1,000,000.00Salt Lake City, Utah March 5, 2019 THIS AMENDED & RESTATED PROMISSORY NOTE AMENDS AND RESTATES IN ITS ENTIRETY THAT CERTAIN PROMISSORY NOTE, DATED JANUARY 17, 2019, IN THE ORIGINAL PRINCIPAL AMOUNT OF $750,000.00 (the “Original Note”), INCREASING THE PRINCIPAL AMOUNT OF SAID ORIGINAL NOTE TO $1,000,000.00. 1.PROMISE TO |
|
| January 27, 2020 |
EX-10 7 ex10.9vedgar1vamd2.htm PROMISSORY NOTE $500,000 December 2, 2019 FOR VALUE RECEIVED, the undersigned (“Maker”) promises to pay ATLANTA INCOME & ASSET GROUP, INC., a Utah corporation (“Holder”), the sum of Five Hundred Thousand and 00/100 United States Dollars and No Cents ($500,000.00), together with interest at the Applicable Rate (as defined below) per annum on the unpaid principal, paya |
|
| January 27, 2020 |
CONTRIBUTION AND SUBSCRIPTION AGREEMENT THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. |
|
| January 27, 2020 |
8-K/A 1 8-kvedgar1amd1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 5, 2019 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commis |
|
| January 24, 2020 |
CONTRIBUTION AND SUBSCRIPTION AGREEMENT EX-2 2 ex2.1vedgar1.htm THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE UPON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THE SECURITIES ACQUIRED HEREUNDER MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SE |
|
| January 24, 2020 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION AMENDED AND RESTATED ARTICLES OF INCORPORATION Bioethics, Ltd., a corporation organized and existing under the laws of the State of Nevada, hereby certifies as follows: 1.The name of the corporation is Bioethics, Ltd. The corporation was originally incorporated under the name of Bioethics, Ltd., and the original Articles of Incorporation of the corporation were filed with the Secretary of State of |
|
| January 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): December 5, 2019 Bioethics, Ltd. (Exact name of Registrant as specified in its charter) Nevada 333-55254-41 87-045312 (State or other jurisdiction (Commission File No.) (IRS Employer |
|
| January 24, 2020 |
ASSIGNMENT OF LEASES AND RENTS WHEN RECORDED, PLEASE RETURN TO: Parr Brown Gee & Loveless 101 South 200 East, Suite 700 Salt Lake City, Utah 84111 Attention: Robert A. |
|
| January 24, 2020 |
AMENDED & RESTATED PROMISSORY NOTE EX-10 4 ex10.6vedgar1.htm AMENDED & RESTATED PROMISSORY NOTE $1,000,000.00Salt Lake City, Utah March 5, 2019 THIS AMENDED & RESTATED PROMISSORY NOTE AMENDS AND RESTATES IN ITS ENTIRETY THAT CERTAIN PROMISSORY NOTE, DATED JANUARY 17, 2019, IN THE ORIGINAL PRINCIPAL AMOUNT OF $750,000.00 (the “Original Note”), INCREASING THE PRINCIPAL AMOUNT OF SAID ORIGINAL NOTE TO $1,000,000.00. 1.PROMISE TO PAY. |
|
| January 24, 2020 |
EX-10 8 ex99.1vedgar1.htm FOR IMMEDIATE RELEASE: January 23, 2020 Mark Scharmann Bioethics, LTD. BOTH 801-543-9302 [email protected] Bioethics LTD. Announces New Course for the Public Company Bioethics and First Federal Management Enter into an Agreement Salt Lake City, Utah: On December 5, 2019, Bioethics LTD. and First Federal Management Corporation entered into a contribution and subscrip |
|
| January 24, 2020 |
PROMISSORY NOTE $640,000.00Salt Lake City, Utah December, 2019 1.PROMISE TO PAY. FOR VALUE RECEIVED, GREEN HAVEN HOMES, LLC, a Utah limited liability company (“Maker”), with a business address of 13504 South, 7530 West, Herriman, Utah 84096, Attn: Joseph L. Darger, promises to pay to the order of BIOETHICS, LTD., a Nevada corporation, its successors or assigns (“Holder”), whose mailing address is |
|
| January 24, 2020 |
EX-10 7 ex10.9vedgar1.htm PROMISSORY NOTE $500,000 December 2, 2019 FOR VALUE RECEIVED, the undersigned (“Maker”) promises to pay ATLANTA INCOME & ASSET GROUP, INC., a Utah corporation (“Holder”), the sum of Five Hundred Thousand and 00/100 United States Dollars and No Cents ($500,000.00), together with interest at the Applicable Rate (as defined below) per annum on the unpaid principal, payable a |
|
| November 14, 2019 |
BOTH / Bioethics, Ltd. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. |
|
| November 14, 2019 |
BOTH / Bioethics, Ltd. NT 10-Q - - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: September 30, 2019 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10- |
|
| August 14, 2019 |
BOTH / Bioethics, Ltd. 10-Q - Quarterly Report - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exa |
|
| May 15, 2019 |
BOTH / Bioethics, Ltd. 10-Q Quarterly Report 10-Q 1 f2019-03-31bioethics10qv5bve.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2019 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Com |
|
| March 19, 2019 |
BOTH / Bioethics, Ltd. (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2018 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NEVADA 87-0485312 (State or other jurisdiction of incorporation or organization) (I.R.S |
|
| November 13, 2018 |
BOTH / Bioethics, Ltd. 10-Q (Quarterly Report) Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 14, 2018 |
BOTH / Bioethics, Ltd. 10-Q (Quarterly Report) Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 15, 2018 |
BOTH / Bioethics, Ltd. 10-Q (Quarterly Report) Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 15, 2018 |
BOTH / Bioethics, Ltd. NT 10-Q SEC FILE NUMBER: 000 30239 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 17, 2018 |
BOTH / Bioethics, Ltd. 10-K (Annual Report) 10-K 1 f2017bioethics10kv6vedgar2.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2017 Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name of registrant as specified in charter) NEVADA 87-0485312 (State or other jurisdiction of |
|
| April 17, 2018 |
Pritchett, Siler & Hardy, PC Certified Public Accountants EX-16 2 bothchangeinauditor8kexhibit.htm Pritchett, Siler & Hardy, PC Certified Public Accountants Exhibit 16.1 April 3, 2018 Securities and Exchange Commission 100 F. Street Washington, DC 20549 - 7561 Re: Bioethics, Ltd. Commission File No. 333-55254-41 We have read the statements that we understand Bioethics, Ltd. will include under Item 4.01 of the Form 8-K report dated April 3, 2018 and agree |
|
| April 17, 2018 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 2, 2018 |
BOTH / Bioethics, Ltd. NT 10-K/A Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 Amendment #1 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| April 2, 2018 |
BOTH / Bioethics, Ltd. NT 10-K NT 10-K 1 bioethics20171231form12b25v0.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2017 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on For |
|
| March 8, 2018 |
Converted by EDGARwiz SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 8, 2018 BIOETHICS, LTD. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-55254-41 87-045312 (Commission Fi |
|
| February 22, 2018 |
Converted by EDGARwiz SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 16, 2018 BIOETHICS, LTD. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 333-55254-41 87-045312 (Commissio |
|
| February 22, 2018 |
BOTH / Bioethics, Ltd. (Current Report) Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2017 BIOETHICS, LTD. |
|
| February 22, 2018 |
Certificate of Designation (PURSUANT TO NRS 78.1955) Converted by EDGARwiz BARBARA K. CEGAVSKE Secretary of State 202 North Carson Street Carson City, Nevada 89701-4201 (775) 684-5708 Website: www.nvsos.gov *150103* *150103* Certificate of Designation (PURSUANT TO NRS 78.1955) USE BLACK INK ONLY· DO NOT HIGHLIGHT ABOVE SPACE IS FOR OFFICE USE ONLV Certificate of Designation For Nevada Profit Corporations (Pursuant to NRS 78.1955) 1. Name of corporat |
|
| November 13, 2017 |
BOTH / Bioethics, Ltd. 10-Q (Quarterly Report) Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 4, 2017 |
BOTH / Bioethics, Ltd. 10-Q (Quarterly Report) Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 17, 2017 |
10-Q 1 f20170331bioethics10qv6vedga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Com |
|
| May 15, 2017 |
SEC FILE NUMBER: 000 30239 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 7, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact |
|
| March 31, 2017 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2016 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 14, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 15, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 15, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 13, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 13, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2015 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact na |
|
| March 31, 2016 |
Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: December 31, 2015 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
|
| November 10, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 11, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 6, 2015 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD |
|
| March 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) Form 10-K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A (Mark One) X .QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 .TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETH |
|
| November 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) X .QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 .TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHIC |
|
| August 19, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 14, 2014 |
BOTH / Bioethics, Ltd. NT 10-Q - - JUNE 30, 2014 10-Q EXTENSION March 31, 2014 10-Q Extension SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 33-55254-41 CUSIP Number: 09059E100 (Check One) . Form 10-K . Form 20-F . 11-K X . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For Period Ended: JUNE 30, 2014 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report |
|
| July 8, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 7, 2014 BIOETHICS, LTD. (Exact Name of Registrant as Specified in Charter) Nevada 33-55254-41 87-0485312 (State of Other Jurisdiction (Commission File (IRS Employer Of Incorpora |
|
| June 25, 2014 |
Amended and Restated Articles of Incorporation of Bioethics, Ltd. EX-3.1 2 ex3irestatedarticles.htm AMENDED AND RESTATED ARTICLES OF INCORPORATION OF BIOETHICS, LTD. Exhibit 3(i) AMENDED AND RESTATED ARTICLES OF INCORPORATION Bioethics, Ltd., a corporation organized and existing under the laws of the State of Nevada, hereby certifies as follows: 1. The name of the corporation is Bioethics, Ltd. The corporation was originally incorporated under the name of Bioeth |
|
| June 25, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2014 BIOETHICS, LTD. (Exact Name of Registrant as Specified in Charter) Nevada 33-55254-41 87-0485312 (State of Other Jurisdiction (Commission File (IRS Employer Of Incorpora |
|
| June 25, 2014 |
Amended and Restated Bylaws of Bioethics, Ltd. Exhibit 3(ii) AMENDED AND RESTATED BYLAWS OF BIOETHICS, LTD. Article 1 Identification Section 1.01. Name. The name of the Corporation is BIOETHICS, LTD. Section 1.02. Resident Agent and Address. The Name of the Resident Agent is Registered Agent Inc., with such street address as set forth in the Articles of Incorporation. The Resident Agent shall maintain at the Registered Office. (a) A copy certi |
|
| May 20, 2014 |
EX-10.1 2 f10q033114ex10z1.htm EXHIBIT 10.1 PROMISSORY NOTE Exhibit 10.1 Salt Lake City, Utah January 27, 2014 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (“Payee”), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Five Thousand Dollars ($5,000.00), together with interest thereon at the rate of |
|
| May 20, 2014 |
Exhibit 10.2 Salt Lake City, Utah March 24, 2014 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (?Payee?), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Six Thousand Dollars ($6,000.00), together with interest thereon at the rate of six percent (6%) per annum, payable upon demand. This Note may |
|
| May 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, |
|
| May 15, 2014 |
- MARCH 31, 2014 10-Q EXTENSION NT 10-Q 1 nt10q033114nt10q.htm MARCH 31, 2014 10-Q EXTENSION SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 33-55254-41 CUSIP Number: 09059E100 (Check One) . Form 10-K . Form 20-F . 11-K X . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For Period Ended: MARCH 31, 2014 . Transition Report on Form 10-K . Transition Report |
|
| March 21, 2014 |
Form 10-K Annual Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 12, 2013 |
FORM 10-Q Quarterly Report September 30 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 14, 2013 |
Promissory Note dated May 10, 2013 Exhibit 10.1 Salt Lake City, Utah May 10, 2013 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (?Payee?), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Ten Thousand Dollars ($10,000.00), together with interest thereon at the rate of six percent (6%) per annum, payable upon demand. This Note may |
|
| August 14, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, |
|
| May 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q 10-Q 1 f10q03311310q.htm FORM 10-Q QUARTERLY REPORT MARCH 31 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the trans |
|
| March 29, 2013 |
Promissory Note dated January 18, 2010 EX-10.1 2 f10k123112ex10z1.htm EXHIBIT 10.1 PROMISSORY NOTE Exhibit 10.1 $25,000.00 Salt Lake City, Utah January 18, 2010 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (“Payee”), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Twenty Five Thousand Dollars ($25,000.00), together with interest the |
|
| March 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K 10-K 1 f10k12311210k.htm FORM 10-K ANNUAL REPORT DECEMBER 31 2012 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2012 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period fr |
|
| November 1, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOET |
|
| November 1, 2012 |
Promissory Note dated July 16, 2012 Exhibit 10.1 Salt Lake City, Utah July 16, 2012 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (?Payee?), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Twenty Thousand Dollars ($20,000.00), together with interest thereon at the rate of six percent (6%) per annum, payable upon demand. This Note |
|
| August 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, |
|
| May 14, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q March 31, 2011 10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) X . ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2011 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact na |
|
| November 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETH |
|
| August 26, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION 10-Q/A 1 bioethics10qa063011.htm JUNE 30, 2011 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q/A Amendment No. 1 (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the |
|
| August 15, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 . TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, |
|
| August 15, 2011 |
Promissory Note dated May 10, 2011 EX-10 2 bioethics10q063011ex101.htm EX 10.1 PROMISSORY NOTE Exhibit 10.1 $5,000.00 Salt Lake City, Utah May 10, 2011 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (“Payee”), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Five Thousand Dollars ($5,000.00), together with interest thereon at the r |
|
| August 15, 2011 |
Promissory Note dated June 27, 2011 Exhibit 10.2 $20,000.00 Salt Lake City, Utah June 27, 2011 PROMISSORY NOTE FOR VALUE RECEIVED, the undersigned Bioethics, Ltd. promises to pay to the order of Banyan Investment Company (?Payee?), at 539 East Blackhawk Lane, Alpine, Utah 84004, the principal amount of Twenty Thousand Dollars ($20,000.00), together with interest thereon at the rate of six percent (6%) per annum, payable upon demand. |
|
| May 13, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2011 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETH |
|
| March 29, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) [ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exac |
|
| November 1, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BI |
|
| August 11, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHI |
|
| May 10, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2010 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETH |
|
| March 29, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) [ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exac |
|
| November 5, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BI |
|
| September 2, 2009 |
8-K 1 form8k082809.htm FORM 8-K DATED AUGUST 28, 2009 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 28, 2009 BIOETHICS, LTD. (Exact Name of Registrant as Specified in Its Charter) Nevada (State or Other Jurisdiction of Incorporation) 33 |
|
| August 12, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LT |
|
| May 15, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION 10-Q 1 q033109.htm 10-Q ENDED MARCH 31, 2009 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 5(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| April 14, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2008 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHICS, LTD. (Exact name |
|
| March 31, 2009 |
NT 10-K 1 ntk123108.htm EXTENSION FOR FILING 10-K YEAR ENDED 12/31/08 UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0058 Expires: April 30, 2009 Washington, D.C. 20549 Estimated average burden hours per response 2.50 FORM 12b-25 SEC FILE NUMBER 33-55254-41 NOTIFICATION OF LATE FILING CUSIP NUMBER 09059E100 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10- |
|
| March 30, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2007 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 33-55254-41 BIOETHI |
|
| February 25, 2009 |
MARK N. SCHNEIDER A PROFESSIONAL CORPORATION 4764 SOUTH 900 EAST, SUITE 3-C TELEPHONE: (801) 263-3576 ATTORNEY AT LAW SALT LAKE CITY, UTAH 84117 FACSIMILE: (801) 685-0949 February 24, 2009 Ethan Horowitz Staff Accountant United States Securities and Exchange Commission 100 F Street, N.E., Mail Stop 3561 Washington, D.C. 20549 Re: Bioethics, Ltd. Form 10-KSB for Fiscal Year Ended December 31, 2007 |
